You are here

  • Home
  • Archive
  • Volume 2, Issue 1
  • Radioimmunotargeting in ovarian carcinoma patients with indium-111 labeled monoclonal antibody OV-TL 3 F(ab′)2: pharmacokinetics, tissue distribution, and tumor imaging

Article metrics

Article menu
Download PDFPDF
Original Articles
Radioimmunotargeting in ovarian carcinoma patients with indium-111 labeled monoclonal antibody OV-TL 3 F(ab′)2: pharmacokinetics, tissue distribution, and tumor imaging

 

Online download statistics by month:

Online download statistics by month: January 2019 to March 2023

AbstractFullPdf
Jan 2019400
Feb 20191602
Mar 2019600
Apr 20191500
May 2019600
Jun 2019600
Jul 2019800
Aug 2019600
Sep 2019400
Oct 2019603
Nov 2019200
Dec 2019400
Jan 20201600
Feb 2020400
Apr 2020601
May 20201600
Jun 20202001
Jul 20201000
Aug 2020600
Sep 2020800
Oct 20201400
Nov 2020600
Dec 20201000
Jan 2021803
Feb 2021200
Mar 20211200
May 2021101
Oct 20211000
Nov 2021400
Dec 2021600
Jan 20221000
Feb 20221000
Mar 20222200
Apr 20221400
May 20223400
Jun 20224000
Jul 20221600
Aug 20224900
Sep 20223900
Oct 20223200
Nov 20222200
Dec 20221000
Jan 2023500
Feb 20233600
Mar 2023200
Total583011